Today, Vireo Advisors is joining the NNI and nanotechnology-related organizations around the US in celebrating the 20th anniversary of the 21st Century Nanotechnology Research and Development Act.

Our latest roundup includes news about regulatory actions on nanomaterials, food additives, bisphenols and partially hydrogenated oils; new databases for exposure assessment data and regulatory information; company news from UBQ, Performance Biofilaments Inc., Conagen and Amyris, Inc.; and publication of notable papers on safety assessment and safe and sustainable by design (SSbD) approaches.

Impactful updates to environmental, health and safety regulations and assessment methods for chemicals, advanced materials and foods headline our latest new roundup.

Vireo has been working for the past decade to establish safety and support commercialization for microfibrillated cellulose, cellulose nanocrystals and a host of other emerging biomaterials. Our lead scientists are sharing their experience and provide practical guidance in presentations, posters, discussion panels and networking events at the 2023 TAPPI Nanotechnology Conference.

The last few weeks have seen a number of announcements related to nano and sustainable materials testing, regulation and commercialization. These are some of the top stories that caught our eyes: